Post-marketing surveillance of donepezil hydrochloride Dementia with Lewy bodies/long-term administratio
Not Applicable
- Conditions
- Dementia with Lewy bodies
- Registration Number
- JPRN-jRCT1080222854
- Lead Sponsor
- Eisai Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
ARICEPT-naive patients diagnosed as Dementia with Lewy bodies
Exclusion Criteria
1)Patients with a history of donepezil hydrochloride product administration in the past.
2)Patients who have already been registered in this surveillance.
3)Patients with a history of hypersensitivity to any ingredients of ARICEPT or piperidine derivatives.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cognitive function<br><br>MMSE or HDS-R
- Secondary Outcome Measures
Name Time Method